These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28698321)
21. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Hsu J; Santesso N; Mustafa R; Brozek J; Chen YL; Hopkins JP; Cheung A; Hovhannisyan G; Ivanova L; Flottorp SA; Saeterdal I; Wong AD; Tian J; Uyeki TM; Akl EA; Alonso-Coello P; Smaill F; Schünemann HJ Ann Intern Med; 2012 Apr; 156(7):512-24. PubMed ID: 22371849 [TBL] [Abstract][Full Text] [Related]
22. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Kaiser L; Keene ON; Hammond JM; Elliott M; Hayden FG Arch Intern Med; 2000 Nov; 160(21):3234-40. PubMed ID: 11088083 [TBL] [Abstract][Full Text] [Related]
23. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. Kawai N; Ikematsu H; Iwaki N; Maeda T; Kanazawa H; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Nagai T; Horii S; Hirotsu N; Kashiwagi S J Infect; 2008 Jan; 56(1):51-7. PubMed ID: 17936910 [TBL] [Abstract][Full Text] [Related]
24. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Jefferson TO; Demicheli V; Di Pietrantonj C; Jones M; Rivetti D Cochrane Database Syst Rev; 2006 Jul; (3):CD001265. PubMed ID: 16855962 [TBL] [Abstract][Full Text] [Related]
25. Oseltamivir: new preparation. An antiviral agent with little impact on influenza. Prescrire Int; 2003 Jun; 12(65):85-8. PubMed ID: 12825569 [TBL] [Abstract][Full Text] [Related]
26. Neuraminidase inhibitors for preventing and treating influenza in children. Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931 [TBL] [Abstract][Full Text] [Related]
27. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. Gravenstein S; Drinka P; Osterweil D; Schilling M; Krause P; Elliott M; Shult P; Ambrozaitis A; Kandel R; Binder E; Hammond J; McElhaney J; Flack N; Daly J; Keene O J Am Med Dir Assoc; 2005; 6(6):359-66. PubMed ID: 16286056 [TBL] [Abstract][Full Text] [Related]
28. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial. Li M; Han GC; Chen Y; Du WX; Liu F; Chi YM; Du JF Braz J Med Biol Res; 2020; 54(2):e9542. PubMed ID: 33263644 [TBL] [Abstract][Full Text] [Related]
30. Neuraminidase inhibitors for preventing and treating influenza in children. Wang K; Shun-Shin M; Gill P; Perera R; Harnden A Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949 [TBL] [Abstract][Full Text] [Related]
31. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Hedrick JA; Barzilai A; Behre U; Henderson FW; Hammond J; Reilly L; Keene O Pediatr Infect Dis J; 2000 May; 19(5):410-7. PubMed ID: 10819336 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590 [TBL] [Abstract][Full Text] [Related]
33. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Jefferson T; Jones M; Doshi P; Del Mar C; Dooley L; Foxlee R Cochrane Database Syst Rev; 2010 Feb; 2011(2):CD001265. PubMed ID: 20166059 [TBL] [Abstract][Full Text] [Related]
34. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. Davey RT; Fernández-Cruz E; Markowitz N; Pett S; Babiker AG; Wentworth D; Khurana S; Engen N; Gordin F; Jain MK; Kan V; Polizzotto MN; Riska P; Ruxrungtham K; Temesgen Z; Lundgren J; Beigel JH; Lane HC; Neaton JD; Lancet Respir Med; 2019 Nov; 7(11):951-963. PubMed ID: 31582358 [TBL] [Abstract][Full Text] [Related]
35. Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter. Blanchon T; Mentré F; Charlois-Ou C; Dornic Q; Mosnier A; Bouscambert M; Carrat F; Duval X; Enouf V; Leport C; Clin Microbiol Infect; 2013 Feb; 19(2):196-203. PubMed ID: 22264308 [TBL] [Abstract][Full Text] [Related]
36. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195 [TBL] [Abstract][Full Text] [Related]
37. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Ikematsu H; Kawai N Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296 [TBL] [Abstract][Full Text] [Related]
38. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial. McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067 [TBL] [Abstract][Full Text] [Related]
39. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502 [TBL] [Abstract][Full Text] [Related]
40. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Butler CC; van der Velden AW; Bongard E; Saville BR; Holmes J; Coenen S; Cook J; Francis NA; Lewis RJ; Godycki-Cwirko M; Llor C; Chlabicz S; Lionis C; Seifert B; Sundvall PD; Colliers A; Aabenhus R; Bjerrum L; Jonassen Harbin N; Lindbæk M; Glinz D; Bucher HC; Kovács B; Radzeviciene Jurgute R; Touboul Lundgren P; Little P; Murphy AW; De Sutter A; Openshaw P; de Jong MD; Connor JT; Matheeussen V; Ieven M; Goossens H; Verheij TJ Lancet; 2020 Jan; 395(10217):42-52. PubMed ID: 31839279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]